InsidersTradesSigma
Follow the NeuroSense Therapeutics Ltd. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 17 June 2026 (Acquisition). Among the most active insiders: Ben-Noon Alon. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
NeuroSense Therapeutics Ltd. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the NASDAQ.